Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses.
about
RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phaseBiocorrosion of magnesium alloys: a new principle in cardiovascular implant technology?In-stent stenosis: pathology and implications for the development of drug eluting stentsLong-term outcome after coronary stentingCombining short stent implantation and drug-eluting stenting for routine use yields a low restenosis rateThe Many Faces of the A2b Adenosine Receptor in Cardiovascular and Metabolic DiseasesNon-steroidal anti-inflammatory drugs (NSAIDs) inhibit vascular smooth muscle cell proliferation via differential effects on the cell cycleStarc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stentingLithium chloride inhibits vascular smooth muscle cell proliferation and migration and alleviates injury-induced neointimal hyperplasia via induction of PGC-1αMacrophage responses to vascular stent coatings.N-acetylcysteine inhibited nuclear factor-kappaB expression and the intimal hyperplasia in rat carotid arterial injury.A novel technique for loading of paclitaxel-PLGA nanoparticles onto ePTFE vascular grafts.Association between VEGF Gene Polymorphisms and In-Stent Restenosis after Coronary Intervention Treated with Bare Metal Stent.Effects of metal coverage rate of flow diversion device on neointimal growth at side branch ostium and stented artery: an animal experiment in rabbit abdominal aorta.Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice.Stent-induced coronary artery stenosis characterized by multimodal nonlinear optical microscopy.Computational fluid dynamics and stent design.Stretch-sensitive down-regulation of the miR-144/451 cluster in vascular smooth muscle and its role in AMP-activated protein kinase signalingNew catheter-based technology for the treatment of restenosis.Therapeutic potential of active stent coating.Early experiences and clinical implications of drug-eluting stents: part 1.In stent restenosis: bane of the stent era.Multilayered electrospun fibrous meshes for restenosis-suppressing metallic stents.Will the potential of peroxisome proliferator-activated receptor agonists be realized in the clinical setting?Intimal Thickening after Placement of a Neuroform Stent. Its Incidence and Relation to Angiographic Follow-up Results of Aneurysm EmbolizationDrug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease.Distinctive effects of CD34- and CD133-specific antibody-coated stents on re-endothelialization and in-stent restenosis at the early phase of vascular injuryPreclinical restenosis models: challenges and successes.Disappearance of a small intracranial aneurysm as a result of vessel straightening and in-stent stenosis following use of an Enterprise vascular reconstruction devicePostmortem pathological examination of a case one month after carotid artery stenting.Techniques in Vascular and Interventional Radiology Drug Delivery Technologies in the Superficial Femoral ArteryA fibronectin-fibrinogen-tropoelastin coating reduces smooth muscle cell growth but improves endothelial cell functionBeta-arrestins regulate atherosclerosis and neointimal hyperplasia by controlling smooth muscle cell proliferation and migrationDrug- and Gene-eluting Stents for Preventing Coronary Restenosis.Preclinical models of restenosis and their application in the evaluation of drug-eluting stent systems.Predictive value of C-reactive protein after drug-eluting stent implantation.Pathogen burden, inflammation, proliferation and apoptosis in human in-stent restenosis. Tissue characteristics compared to primary atherosclerosis.Long-term outcome of percutaneous coronary intervention: the significance of native coronary artery disease progression.A2 adenosine receptors and vascular pathologies.Surface chemical and physical modification in stent technology for the treatment of coronary artery disease.
P2860
Q24291853-B2DDA66F-79FB-455B-B75E-3529C6E39A78Q24674425-FF726822-A47C-4723-9BD2-3399290E7E1CQ24674571-B689C2B2-7EBD-4898-AA81-ABF3D30B0AE6Q24792495-D74B8D0B-2198-4FC2-B948-6499CD7BBFD1Q25257554-8F957741-C715-4ACC-A21C-2B6DB9BDEBC9Q28080657-ABF21392-EF92-459A-92E5-6DF89AE4D99AQ28196440-D319F6E7-E241-4EC1-BADE-25219D3F214FQ28218296-ECA67E60-2185-4C32-B522-97AC595F3739Q28485853-829B26E5-3D5C-4AEA-A023-5E2042AE3DFDQ30834421-0688D69B-042E-4BAF-920E-139E378B2623Q31027190-F159D42B-C026-4C46-9ECE-2DC2EAAD92BAQ33283046-6376491B-62A5-43D5-A195-93771D9A9603Q33623845-327D82C6-1646-4C74-94BF-5520A773426EQ34101309-2867C09F-1321-49F2-8AE1-9EDAEA66B581Q34500809-3C67D253-F4DF-4862-8789-DFABE69B47FFQ34661482-0FB4FE7B-9A7A-4CF8-89D9-DBF23C343901Q34703479-AF090F83-F9C5-46F0-973E-546C6422E4C8Q34738318-8FC2DDB6-187B-4754-8E5A-C0FE1281575FQ35002613-8D8D8E63-EEC4-462F-8D30-E1BF1CE5EF8BQ35117070-80481A62-7038-4255-928C-D606527A5EA3Q35651217-CD2A064F-45C0-46D8-B7C6-7A82DB5A504DQ35769824-5E9E713C-F2F5-40FC-9E42-00DB80835742Q35869846-5094E7E2-2DB0-4552-B8AB-D8E24FA413ACQ35911584-4D2C43C6-BC57-44D3-9FE3-42A1BAD020E2Q35937571-997D9AD5-8204-43D4-913B-0D0E973020A6Q35945466-1B2B61E7-B54B-4C68-B870-45FD246FC8D7Q36345131-9E21F396-4981-45E3-BE86-8ADF4D255E9CQ36409436-C6F9C63F-69A3-4D89-972C-DEC98CC9C8B7Q36705180-829E1B46-9FA6-48C1-9637-0D861DA5474DQ36938587-5B638ACF-40A6-4FC1-921C-02802ECE5C06Q37102287-3D4B19C9-3392-45B0-A3E6-8DE663734F51Q37294925-2FB658A3-A1F0-4551-B4C7-8710A9EFAEBDQ37383096-B904761F-10C7-43FC-9BEC-CD1528A80300Q37633078-470AEA4A-3431-4F44-818F-29C6245C10A1Q37676695-74771BF2-F8CF-48A3-A609-A9BC698D7E45Q37709401-637E97F6-4A44-43C1-AE88-0DC1389DD601Q37866127-D83EBE3A-8E50-4AA7-A05F-3D2729200466Q37935706-D4ECD559-AD7A-43DD-8143-A11EB31A595DQ37994174-A7E990E1-A87F-487E-B93D-8B35E18463A6Q38040738-D0842856-A17D-4A57-ACC9-782A19F55A34
P2860
Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Neointimal tissue response at ...... immunohistochemical analyses.
@en
Neointimal tissue response at ...... immunohistochemical analyses.
@nl
type
label
Neointimal tissue response at ...... immunohistochemical analyses.
@en
Neointimal tissue response at ...... immunohistochemical analyses.
@nl
prefLabel
Neointimal tissue response at ...... immunohistochemical analyses.
@en
Neointimal tissue response at ...... immunohistochemical analyses.
@nl
P2093
P356
P1433
P1476
Neointimal tissue response at ...... immunohistochemical analyses.
@en
P2093
P304
P356
10.1161/01.CIR.98.3.224
P407
P577
1998-07-01T00:00:00Z